Fibrosis
116
13
19
61
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
17 trials with published results (15%)
Research Maturity
61 completed trials (53% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.2%
6 terminated out of 116 trials
91.0%
+4.5% vs benchmark
10%
12 trials in Phase 3/4
28%
17 of 61 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 61 completed trials
Clinical Trials (116)
Study of Oral Idebenone to Treat Non-Alcoholic Steatohepatitis
Manual Therapy in Treating Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Evaluation of the Medical Benefit of Spa Therapy on Fibrosis After Radiotherapy for Breast Cancer or UADT (Upper Aerodigestive Tract) Cancer
Copper Supplementation in Cirrhosis
Effectiveness of Percutaneous Electrolysis in Subacute and Early Chronic Medial Gastrocnemius Muscle Injuries
A Study of Mosliciguat in PH-ILD
Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)
Diaphragmatic Function as a Biomarker
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
Growth Hormone in Decompensated Liver Cirrhosis
Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease
Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis With Fibrosis
Blood Collection Biorepository for Liver Disease Research
The Alfred Step Test Exercise Protocol (A-STEP), for Adults With Cystic Fibrosis.
Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19
The Gastric Bypass Stent System as a Treatment for Hepatic Fibrosis in Obese Patients in European Region
Radiological Spectrum Of Fatty Liver Correlate With High Resolution Ultrasonography Of Fibrosis And Cirrhosis
Low-Level Laser in Head and Neck Chronic Lymphedema
Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis